$RKT This is not hype Go through the deck, do your work, and ask yourself: Is Rocket quietly building a $60B juggernaut while Wall Street sleeps?
Andrew Left Breaks Silence on CNBC: Addressing Fraud Allegations and the Future of Short Selling
In a candid and exclusive interview on CNBC’s Squawk Box, Citron Research Founder Andrew Left addressed recent fraud allegations brought against him by the SEC and DOJ. Speaking publicly for the first time since the charges were announced, Left discussed the accusations, his trading practices, and the broader implications for short sellers and market participants.
Watch the full interview here: CNBC Squawk Box with Andrew Ross Sorkin
Published on CNBC Fri, Jan 10 2025
Citron Research Long Vishay Precision Group (NYSE: VPG):, The Hidden Tesla Optimus Play.
Recently Musk’s pronouncements that Tesla’s future is really in robotics, not EVs. Humanoid robots may be a trillion-dollar market.
You cannot escape the hype behind Humanoid Robotics! There are just too many news stories to even start posting.
Humanoid robots are no longer science fiction—they’re Silicon Valley’s next gold rush. Tesla CEO Elon Musk has repeatedly emphasized the scale of Tesla’s Optimus humanoid project, claiming it will overshadow everything else Tesla has built. Yet, remarkably, the market seems oblivious to Vishay Precision Group (VPG), the critical “picks-and-shovels” supplier quietly powering Tesla’s ambitious humanoid plans.
Throwback to 2020: Citron Research Recognized MicroStrategy’s Bitcoin Pivot Before It Became Mainstream
In light of recent developments, it’s worth revisiting our 2020 report, where Citron Research was among the first to introduce the investing public to MicroStrategy as a transformational Bitcoin proxy. At the time, this bold move was underappreciated, but history has since validated the foresight.
We recently turned cautious on MSTR, not just for its Bitcoin holdings but based on valuation metrics that reflect strong fundamentals. This evolution aligns with our ethos: staying ahead of trends while remaining grounded in value.
For those interested, here’s the original report—a testament to the critical analysis Citron brings to market discussions.
;
Small-cap quantum stocks are in a bubble, but $QUBT stands out as the most ridiculous. The numbers tell the story. R&D spending is THE critical indicator in this space: last quarter, $IONQ allocated $33M and $RGTI $12M, modest figures next to tech giants like Google. Yet $QUBT… https://x.com/i/web/status/1869400459267436877
Buying $RGTI based on Google’s quantum success is as misguided as believing every TikTok guitarist is the next Taylor Swift. When the hype fades, investors will recall $RGTI sold equity at $2 just two weeks ago, with more dilution to come rather than true quantum competitiveness.… https://x.com/i/web/status/1866859551166959963
While we have had our share of dogs, it is good to update a success story and put it in perspective 5 months after mention
In July of this year while $RGTI was trading near $1, Citron suggested the stock saying it will be an ultimate beneficiary of a quantum computing hype. 5…
Citron pounding the table that $NBIS is poised to be the next AI Wall Street darling. A sleeper with no analyst coverage yet, the market hasn’t caught on to its massive potential—or its undervaluation vs. CoreWeave. If it trades at a 50% discount to Coreweave multiple that puts… https://x.com/i/web/status/1864018794873495945